As a chemokine, the upregulation of CCL2 and CCL7 promotes the infiltration and activation of inflammatory cells during IPF progression, thereby sustaining lung inflammation (Deng et al., 2013; Krafft et al., 2013; Shinoda et al., 2009). The gene discussed is CCL2; the disease is idiopathic pulmonary fibrosis.